Fosun Pharma
Focus: Fosun Pharma is a public Australian diagnostics and specialty pharmaceutical company founded in 1994, operating across oncology, neurology, cardiovascular, infectious diseases, and respiratory indications with a portfolio of small molecules and traditional therapeutics.
Profile data last refreshed 22h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About Fosun Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Fosun Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Fosun Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Late-stage
6 Phase 3+
LOE Risk
3 in 5yr
BROMSITE
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$66M Part DStable
Peak10.2yr
Revenue anchor representing 24% of company revenue with 11+ years of patent protection remaining.
Help build intelligence for Fosun Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.